A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors
Titel:
A Phase I study to assess the safety, tolerability, and pharmacokinetics of AZD4877, an intravenous Eg5 inhibitor in patients with advanced solid tumors
Auteur:
Infante, J. R. Kurzrock, R. Spratlin, J. Burris, H. A. Eckhardt, S. G. Li, J. Wu, K. Skolnik, J. M. Hylander-Gans, L. Osmukhina, A. Huszar, D. Herbst, R. S.